RSS

Monthly Archives: May 2013

China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device

 
Leave a comment

Posted by on May 27, 2013 in Uncategorized

 

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan

 
Leave a comment

Posted by on May 27, 2013 in Uncategorized

 

Roche wins FDA approval for novel diabetes Dx

 
Leave a comment

Posted by on May 27, 2013 in Uncategorized

 

Growing new brains with infrared light

New Drug Approvals

Illustration of the “neuronal beacon” for guiding axon growth direction (credit: B. Black et al./Optics Letters)


Growing new brains with infrared light

Links

 http://www.kurzweilai.net/growing-new-brains-with-infrared-light?utm_source=KurzweilAI+Daily+Newsletter&utm_campaign=0307f9a402-UA-946742-1&utm_medium=email&utm_term=0_6de721fb33-0307f9a402-282116853

    University of Texas Arlington scientists have discovered a way to control the growth or repair of neurons and neuron circuits, using a non-invasive “neuronal beacon” (near-IR laser beam) — essentially rewiring brains, or even creating new ones. This major discovery, just published in Optics Letters, promises to enable several new applications, UT Arlington assistant professor … more…

View original post

 
Leave a comment

Posted by on May 27, 2013 in Uncategorized

 

Ferring Presents Phase III Data for a Controlled Release Misoprostol Vaginal Delivery System for Labour Induction at the First European Congress on Intrapartum Care

New Drug Approvals

MISOPROSTOL

READ AT

http://www.nationalpost.com/markets/news/Ferring%2BPresents%2BPhase%2BData%2BControlled%2BRelease%2BMisoprostol%2BVaginal/8429878/story.html

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that is used for the prevention of nonsteroidal anti-inflammatory drug (NSAID) induced gastric ulcers, to treat missed miscarriage, to induce labor, and as an abortifacient. The latter use is controversial in theUnited States. Misoprostol was invented and marketed by G.D. Searle & Company (nowPfizer) under the trade name Cytotec, but other brand-name and generic formulations are now available as well.

Misoprostol is approved for use in the prevention of NSAID induced gastric ulcers. It acts upon gastric parietal cells, inhibiting the secretion of gastric acid via G-protein coupled receptor mediated inhibition of adenylate cyclase, which leads to decreased intracellularcyclic AMP levels and decreased proton pump activity at the apical surface of the parietal cell. Because

View original post

 
Leave a comment

Posted by on May 26, 2013 in Uncategorized

 

Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine

New Drug Approvals

preladenant

Merck , known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Merck’s investigational adenosine A2A receptor antagonist for the treatment of Parkinson’s disease (PD). An initial review of data from three separate Phase III trials did not provide evidence of efficacy for preladenant compared with placebo…..read more at

Links

http://www.businesswire.com/news/home/20130523006358/en/Merck-Update-Phase-III-Clinical-Program-Preladenant

Preladenant (SCH 420814) was a drug that was developed by Schering-Plough which acted as a potent and selective antagonist at the adenosine A2A receptor. It was being researched as a potential treatment for Parkinson’s disease.Positive results were reported in Phase II clinical trials in humans, but it did not prove itself to be more effective than a placebo during Phase III trials, and so was discontinued in May 2013

View original post

 
Leave a comment

Posted by on May 26, 2013 in Uncategorized

 

DRUG POLYMORPHISM, EVERYTHING AT ONE PLACE BY DR ANTHONY CRASTO

 
Leave a comment

Posted by on May 26, 2013 in Uncategorized

 
 
DRUG REGULATORY AFFAIRS INTERNATIONAL

Drug Regulatory affairs by DR ANTHONY MELVIN CRASTO, Worlddrugtracker

Seven Spheres

Aqua Terra Ignis et Aer

Chemtips

Because Organic Chemistry is Hard Enough

Fathisaffar

A Blog by Mohamed Fathi SAFFAR Pharm.D;Docteur es-sciences Pharmaceutiques;GMP-Inspector; Director at NATIONAL LABORATORY FOR DRUG CONTROL

%d bloggers like this: